Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Par Pharmaceutical Companies, Inc.    PRX   US69888P1066

SummaryChart AnalysisNewsCalendarCompanyFinancialsForum 

PAR PHRAM : Par Pharmaceutical Companies to Report Second Quarter 2010 Results on August 4, 2010

07/08/2010| 09:05am US/Eastern
Recommend:
0

WOODCLIFF LAKE, N.J., July 8 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) announced today that it will host a conference call and live webcast on Wednesday, August 4, 2010 at 9:00AM EDT to review results for the second quarter 2010. Par will release its financial results on August 4, 2010 before the market opens.

Access to the live webcast can be made via the Company's website at www.parpharm.com.


    Dial-in Information
    -------------------
    Domestic:            800-659-2056
    International:       617-614-2714
    Passcode:                71836499

A replay of the conference call will be available for two weeks approximately one hour after the call.


    Replay Information
    ------------------
    Domestic:            888-286-8010
    International:       617-801-6888
    Passcode:                84280770

About Par

Par Pharmaceutical Companies, Inc. is a US-based specialty pharmaceutical company. Through its wholly-owned subsidiary's two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals, it develops, manufactures and markets high barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals. For press release and other company information, visit www.parpharm.com.

SOURCE Par Pharmaceutical Companies, Inc.

Recommend :
0
Partner Area
React to this article
 
Latest news on PAR PHARMACEUTICAL COMPANI
01/18 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Gener..
01/02 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Rizat..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Gener..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Gener..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Acquires Rights To Marke..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Receives Final Approval ..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Announces Completion Of Acquisition By ..
2012DJADT, Pentair to Gain Spots on S&P 500, Replacing Lexmark, DeVry
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Companies Announces The ..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Robbins Geller Rudman & Dowd LLP Files Clas..
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.